Gastric Electrical Stimulators Market to Grow at 6.4% CAGR Through 2030, Reports Persistence Market Research

The global gastric electrical stimulators (GES) market is projected to experience robust growth, with a compound annual growth rate (CAGR) of 6.4% between 2023 and 2030. From a market size of US$250.0 million in 2023, the market is expected to reach US$386.0 million by 2030. This growth is largely attributed to an increasing prevalence of gastroparesis and obesity, two key conditions that are treated with GES technology. Gastroparesis, a disorder that affects the stomach muscles and impairs normal stomach movement, has seen a rise in incidence globally, especially among diabetic individuals. Additionally, with the global obesity crisis continuing to escalate, the demand for advanced treatment options, such as gastric electrical stimulators, is on the rise.

The gastric electrical stimulators market benefits from various key growth drivers, including the increasing recognition of the effectiveness of GES in managing gastroparesis, coupled with favorable reimbursement policies in several regions. Furthermore, there is an increasing emphasis on minimally invasive treatments, which make GES an attractive option for patients with refractory gastroparesis or obesity. The market is characterized by technological advancements, including the development of wireless, rechargeable devices that aim to improve patient experience and reduce the need for frequent surgeries. North America, particularly the United States, is the leading geographical region due to high rates of gastroparesis, widespread adoption of GES devices, and favorable healthcare policies.

✅ Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/25954

Key Highlights from the Report:

✦ The global gastric electrical stimulators market is forecasted to grow at a CAGR of 6.4% from 2023 to 2030.
✦ The market size is expected to increase from US$250.0 million in 2023 to US$386.0 million by 2030.
✦ Gastroparesis and obesity are driving the demand for gastric electrical stimulators.
✦ High-frequency gastric stimulators are expected to remain the leading segment in the market.
✦ North America holds the largest share of the global gastric electrical stimulators market.
✦ Advancements in wireless, rechargeable devices are expected to shape the future of the market.

Market Segmentation

The gastric electrical stimulators market can be divided based on several factors such as product type, end-user, application, and region.

By Product Type

The market is primarily segmented into low-frequency and high-frequency gastric electrical stimulators. High-frequency stimulators are expected to dominate due to their advantages, including longer battery life, reduced invasiveness during implantation, and better patient compliance. High-frequency stimulators are gaining popularity due to their ability to provide more efficient treatment and offer a less invasive alternative compared to low-frequency stimulators. Furthermore, high-frequency systems tend to be more patient-friendly and are associated with fewer complications.

By End-User

The hospital and clinic segment leads in terms of demand for gastric electrical stimulators. This is due to the increasing number of patients being treated for conditions like gastroparesis, which require advanced therapeutic options. Additionally, hospitals are equipped with the necessary infrastructure for implanting these devices. As hospitals expand their capabilities to perform minimally invasive surgeries, the demand for gastric electrical stimulators continues to rise.

By Application

The primary applications of gastric electrical stimulators include gastroparesis management and weight loss treatments. Gastroparesis, particularly in patients with type 1 and type 2 diabetes, is the leading application, as GES offers a unique treatment option for this condition when other medications fail. Weight loss is another growing application, as obesity continues to be a global health concern, and GES technology is being increasingly recognized for its potential in treating this condition.

By Region

The North American region, especially the United States, is the largest market for gastric electrical stimulators, driven by high prevalence rates of gastroparesis, obesity, and favorable regulatory frameworks for medical devices. Asia-Pacific is emerging as a key market due to the growing burden of chronic diseases, increased awareness about gastric electrical stimulators, and expanding healthcare infrastructure. Europe also plays a significant role, driven by the increasing adoption of GES devices for treating obesity and gastroparesis.

✅ Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/25954

Regional Insights

North America

North America is the dominant region in the gastric electrical stimulators market, primarily due to the high prevalence of gastroparesis and obesity in the United States. The market is further supported by the increasing number of gastrointestinal surgical procedures and favorable healthcare reimbursement policies. With a well-established healthcare infrastructure and a focus on advanced medical technologies, the U.S. is expected to maintain its leadership position in the market.

Europe

In Europe, the market for gastric electrical stimulators is growing steadily, with countries such as Germany, France, and the UK showing significant adoption. The availability of advanced medical technologies and the increasing recognition of GES as an effective treatment for gastroparesis are contributing to the market's growth. Furthermore, reimbursement policies in several European nations are conducive to the adoption of GES devices, driving demand across the region.

Asia-Pacific

Asia-Pacific is emerging as a key growth region for gastric electrical stimulators, driven by the rising incidence of obesity, diabetes, and gastrointestinal disorders. The region is seeing an expansion in healthcare infrastructure, along with increased awareness of advanced treatment options like GES. Countries such as China, Japan, and India are expected to witness significant growth, driven by a combination of factors such as rising healthcare investments and an aging population.

Market Drivers

The growth of the gastric electrical stimulators market is driven by multiple factors, with the increasing prevalence of gastroparesis and obesity being the foremost drivers. Gastroparesis, a condition characterized by delayed stomach emptying, is becoming more common, particularly in patients with diabetes. This trend has led to an increased demand for effective treatments like gastric electrical stimulation.

Obesity is another critical factor contributing to market growth. As global obesity rates continue to rise, especially in developed countries, there is a growing need for effective weight loss interventions. GES has shown promising results in weight reduction, further boosting its adoption as an alternative to traditional weight loss treatments. Additionally, the shift towards minimally invasive procedures has played a significant role in the market's expansion. The relatively low-risk nature of GES procedures, combined with the increasing focus on patient-centric care, has made GES an attractive option for both patients and healthcare providers.

Market Restraints

Despite its growth potential, the gastric electrical stimulators market faces several challenges. One of the most significant constraints is the risk of complications associated with the implantation of these devices. Complications such as infection, bleeding, device malfunctions, and lead migration can deter patients from opting for GES therapy. These risks are amplified in patients with underlying conditions, such as obesity or diabetes, which complicate the treatment process.

Another challenge is the lack of FDA approval for obesity treatments using GES devices in certain regions. In the U.S., for example, GES devices have yet to receive FDA approval for use in obesity treatments, although they are approved for gastroparesis. This regulatory hurdle limits the full market potential for GES in treating obesity, particularly in regions where regulatory approval is a major factor in device adoption.

Market Opportunities

The market for gastric electrical stimulators presents several growth opportunities. Innovations in GES technology, including the development of wireless, rechargeable systems, hold the promise of reducing the need for frequent surgical replacements and improving patient satisfaction. These advancements are expected to revolutionize the market and make GES devices more convenient and cost-effective.

Additionally, early diagnosis and the use of IoT-enabled devices are opening new avenues for the treatment of gastroparesis and obesity. IoT devices can help monitor patient progress and adjust stimulation parameters remotely, offering a more personalized approach to treatment. These developments, combined with an increase in preventive healthcare initiatives, present significant opportunities for market players to innovate and meet the evolving needs of patients.

Reasons to Buy the Report

✔ Comprehensive insights into the growth potential of the gastric electrical stimulators market
✔ In-depth analysis of key growth drivers and market restraints
✔ Detailed market segmentation based on product type, end-user, and region
✔ Regional insights and forecasts for North America, Europe, and Asia-Pacific
✔ Strategic recommendations for key players operating in the gastric electrical stimulators market

Company Insights

• Medtronic Plc.
• IntraPace Inc.
• ReShape Lifesciences Inc.
• Changzhou Ruishen Medical Equipment Co. Ltd.
• Chen Tao Medical Equipment
• Rishena Co. Ltd.
• Enterra TM

Recent Developments

In 2021, IntraPace launched the INSPIRES Control wireless gastric electrical stimulator, offering a non-invasive, patient-friendly treatment option.

In March 2020, Medtronic introduced the Enterra II 37800 gastric neurostimulator, designed to treat chronic nausea and vomiting associated with gastroparesis.

Conclusion

The gastric electrical stimulators market is poised for substantial growth, driven by the increasing prevalence of gastroparesis and obesity, as well as technological advancements in GES devices. While the market faces challenges such as complications associated with device implantation and regulatory hurdles, the opportunities provided by innovations in wireless, rechargeable devices and IoT technologies are expected to drive the market forward. With key players continuing to innovate and expand their offerings, the market for gastric electrical stimulators is set to evolve, providing new solutions for patients with gastroparesis and obesity worldwide.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.